Using the NN approach, we tested the extent to which patients of overlap zone in the scatter plot of Fig. 3 (where patients were plotted regarding their scores on the global “Depression” and “Schizophrenia” scales) can be identified through IgM levels in combination with other parameters. This evidence concerns the gene CD40LG and depressive symptom measurement.